| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 184 | 2024 | 12252 | 7.180 |
Why?
|
| Life Style | 67 | 2024 | 3932 | 3.600 |
Why?
|
| Obesity | 97 | 2024 | 13090 | 3.560 |
Why?
|
| Blood Glucose | 70 | 2024 | 6430 | 2.970 |
Why?
|
| Polymorphism, Single Nucleotide | 121 | 2024 | 16045 | 2.920 |
Why?
|
| Metformin | 27 | 2023 | 909 | 2.730 |
Why?
|
| Motor Activity | 36 | 2017 | 2711 | 2.650 |
Why?
|
| Genome-Wide Association Study | 94 | 2025 | 12795 | 2.450 |
Why?
|
| Prediabetic State | 16 | 2024 | 548 | 2.370 |
Why?
|
| Genetic Loci | 25 | 2021 | 2629 | 2.270 |
Why?
|
| Genetic Predisposition to Disease | 86 | 2024 | 18065 | 2.110 |
Why?
|
| Exercise | 44 | 2025 | 5955 | 2.080 |
Why?
|
| Body Mass Index | 84 | 2024 | 13053 | 2.030 |
Why?
|
| Genotype | 76 | 2022 | 13045 | 1.960 |
Why?
|
| Insulin | 47 | 2023 | 6607 | 1.860 |
Why?
|
| Energy Metabolism | 36 | 2020 | 2907 | 1.760 |
Why?
|
| Cardiovascular Diseases | 39 | 2024 | 15662 | 1.720 |
Why?
|
| Genetic Variation | 40 | 2024 | 6611 | 1.680 |
Why?
|
| Sweden | 30 | 2022 | 1382 | 1.570 |
Why?
|
| Insulin Resistance | 35 | 2024 | 3986 | 1.450 |
Why?
|
| Diabetes Mellitus | 21 | 2024 | 5889 | 1.440 |
Why?
|
| Diet | 39 | 2024 | 8089 | 1.370 |
Why?
|
| Physical Fitness | 15 | 2017 | 744 | 1.320 |
Why?
|
| Emigrants and Immigrants | 5 | 2017 | 550 | 1.260 |
Why?
|
| Body Composition | 17 | 2021 | 2462 | 1.240 |
Why?
|
| Fasting | 27 | 2024 | 1610 | 1.220 |
Why?
|
| Lipids | 18 | 2023 | 3343 | 1.200 |
Why?
|
| Humans | 499 | 2025 | 768166 | 1.190 |
Why?
|
| Europe | 49 | 2022 | 3436 | 1.170 |
Why?
|
| Triglycerides | 22 | 2023 | 2464 | 1.160 |
Why?
|
| Blood Pressure | 29 | 2020 | 8543 | 1.150 |
Why?
|
| Adiposity | 17 | 2024 | 1895 | 1.110 |
Why?
|
| Heat-Shock Proteins | 6 | 2009 | 797 | 1.110 |
Why?
|
| Hypertension | 26 | 2022 | 8616 | 1.060 |
Why?
|
| Glucose Intolerance | 10 | 2021 | 579 | 1.040 |
Why?
|
| Glucose Tolerance Test | 23 | 2021 | 1183 | 1.020 |
Why?
|
| Energy Intake | 20 | 2023 | 2146 | 1.020 |
Why?
|
| Genomics | 17 | 2023 | 5926 | 1.010 |
Why?
|
| Risk Factors | 125 | 2023 | 74944 | 0.990 |
Why?
|
| Female | 318 | 2025 | 397192 | 0.950 |
Why?
|
| Body Height | 10 | 2022 | 1565 | 0.910 |
Why?
|
| Waist Circumference | 19 | 2022 | 935 | 0.910 |
Why?
|
| Adult | 230 | 2025 | 223646 | 0.910 |
Why?
|
| Middle Aged | 231 | 2024 | 223492 | 0.910 |
Why?
|
| Risk Reduction Behavior | 8 | 2017 | 1119 | 0.890 |
Why?
|
| Male | 285 | 2024 | 364719 | 0.870 |
Why?
|
| Multifactorial Inheritance | 9 | 2024 | 1422 | 0.840 |
Why?
|
| Body Weight | 18 | 2019 | 4627 | 0.840 |
Why?
|
| Hypoglycemic Agents | 18 | 2022 | 3109 | 0.840 |
Why?
|
| Cholesterol, HDL | 14 | 2020 | 1820 | 0.820 |
Why?
|
| Polymorphism, Genetic | 19 | 2019 | 4249 | 0.820 |
Why?
|
| Postprandial Period | 9 | 2023 | 320 | 0.810 |
Why?
|
| Adipocytes, White | 1 | 2023 | 92 | 0.810 |
Why?
|
| Weight Loss | 16 | 2023 | 2721 | 0.800 |
Why?
|
| Quantitative Trait Loci | 20 | 2022 | 2131 | 0.800 |
Why?
|
| Fatty Acids, Nonesterified | 4 | 2008 | 394 | 0.770 |
Why?
|
| Arabs | 2 | 2014 | 190 | 0.770 |
Why?
|
| Organic Cation Transport Proteins | 3 | 2022 | 61 | 0.760 |
Why?
|
| Glucose | 14 | 2023 | 4352 | 0.750 |
Why?
|
| Gene Frequency | 21 | 2024 | 3623 | 0.750 |
Why?
|
| Lipogenesis | 1 | 2023 | 217 | 0.750 |
Why?
|
| Cholesterol, LDL | 14 | 2022 | 2403 | 0.740 |
Why?
|
| Dietary Fats | 13 | 2020 | 2003 | 0.730 |
Why?
|
| Smoking | 17 | 2019 | 9092 | 0.690 |
Why?
|
| Indians, North American | 8 | 2011 | 354 | 0.690 |
Why?
|
| Prospective Studies | 77 | 2023 | 54926 | 0.680 |
Why?
|
| Homeostasis | 7 | 2020 | 3348 | 0.680 |
Why?
|
| Phenotype | 34 | 2023 | 16726 | 0.660 |
Why?
|
| Cohort Studies | 80 | 2024 | 41754 | 0.660 |
Why?
|
| Family Practice | 11 | 2000 | 509 | 0.650 |
Why?
|
| Genetic Association Studies | 16 | 2019 | 2744 | 0.650 |
Why?
|
| Leptin | 7 | 2016 | 1599 | 0.640 |
Why?
|
| Overweight | 11 | 2019 | 2448 | 0.640 |
Why?
|
| Insulin-Secreting Cells | 8 | 2024 | 899 | 0.630 |
Why?
|
| Pregnancy | 39 | 2025 | 30256 | 0.610 |
Why?
|
| Mortality | 13 | 2020 | 2911 | 0.610 |
Why?
|
| Transcription Factors | 11 | 2019 | 12168 | 0.610 |
Why?
|
| Hyperglycemia | 5 | 2017 | 1388 | 0.600 |
Why?
|
| DNA Methylation | 8 | 2025 | 4428 | 0.590 |
Why?
|
| Proteins | 11 | 2019 | 6009 | 0.580 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2015 | 83 | 0.580 |
Why?
|
| Leukocytes | 6 | 2025 | 2035 | 0.570 |
Why?
|
| Hypertriglyceridemia | 5 | 2016 | 293 | 0.570 |
Why?
|
| Alleles | 28 | 2023 | 6894 | 0.560 |
Why?
|
| Checklist | 1 | 2024 | 840 | 0.560 |
Why?
|
| Mendelian Randomization Analysis | 16 | 2024 | 1040 | 0.560 |
Why?
|
| Consensus | 3 | 2023 | 3212 | 0.550 |
Why?
|
| Metabolic Diseases | 3 | 2018 | 684 | 0.550 |
Why?
|
| Salivary alpha-Amylases | 1 | 2016 | 16 | 0.550 |
Why?
|
| Coronary Artery Disease | 14 | 2022 | 6568 | 0.550 |
Why?
|
| Oxygen Consumption | 10 | 2008 | 1880 | 0.540 |
Why?
|
| Glucose Metabolism Disorders | 2 | 2021 | 52 | 0.530 |
Why?
|
| Biological Specimen Banks | 4 | 2019 | 788 | 0.530 |
Why?
|
| Health Status | 12 | 2018 | 4091 | 0.530 |
Why?
|
| PPAR gamma | 5 | 2018 | 486 | 0.520 |
Why?
|
| Epistasis, Genetic | 4 | 2020 | 353 | 0.520 |
Why?
|
| Aged | 119 | 2024 | 171504 | 0.510 |
Why?
|
| Cholesterol | 6 | 2023 | 2914 | 0.500 |
Why?
|
| Intra-Abdominal Fat | 4 | 2022 | 625 | 0.500 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2018 | 529 | 0.490 |
Why?
|
| Cryptochromes | 1 | 2015 | 49 | 0.490 |
Why?
|
| Bicycling | 1 | 2016 | 177 | 0.490 |
Why?
|
| Cross-Sectional Studies | 45 | 2025 | 26379 | 0.480 |
Why?
|
| Endocrinology | 2 | 2020 | 443 | 0.480 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 2892 | 0.480 |
Why?
|
| Membrane Proteins | 13 | 2021 | 7876 | 0.480 |
Why?
|
| Sleep Deprivation | 1 | 2021 | 848 | 0.480 |
Why?
|
| Residence Characteristics | 5 | 2020 | 2118 | 0.460 |
Why?
|
| Incidence | 41 | 2024 | 21538 | 0.460 |
Why?
|
| Physicians, Family | 5 | 2001 | 349 | 0.460 |
Why?
|
| Maternal-Fetal Relations | 1 | 2014 | 25 | 0.450 |
Why?
|
| Environment | 4 | 2009 | 1121 | 0.450 |
Why?
|
| Periodontitis | 2 | 2019 | 577 | 0.450 |
Why?
|
| Fatty Liver | 1 | 2020 | 809 | 0.440 |
Why?
|
| Odds Ratio | 17 | 2020 | 9669 | 0.430 |
Why?
|
| Gold | 1 | 2017 | 488 | 0.420 |
Why?
|
| Birth Weight | 5 | 2021 | 2121 | 0.420 |
Why?
|
| Heterozygote | 3 | 2018 | 2798 | 0.410 |
Why?
|
| Apolipoprotein A-I | 1 | 2014 | 305 | 0.410 |
Why?
|
| Diabetes, Gestational | 5 | 2022 | 1263 | 0.410 |
Why?
|
| Chromosome Mapping | 8 | 2022 | 4620 | 0.400 |
Why?
|
| Dyslipidemias | 3 | 2018 | 873 | 0.400 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 540 | 0.400 |
Why?
|
| Diabetes Complications | 5 | 2023 | 1320 | 0.400 |
Why?
|
| Tobacco, Smokeless | 1 | 2013 | 133 | 0.390 |
Why?
|
| Dental Caries | 4 | 2020 | 429 | 0.390 |
Why?
|
| Adiponectin | 6 | 2016 | 1117 | 0.390 |
Why?
|
| Case-Control Studies | 38 | 2021 | 22291 | 0.390 |
Why?
|
| Iraq | 4 | 2017 | 93 | 0.390 |
Why?
|
| Waist-Hip Ratio | 13 | 2022 | 520 | 0.390 |
Why?
|
| Adipokines | 1 | 2014 | 309 | 0.390 |
Why?
|
| Dietary Carbohydrates | 7 | 2020 | 896 | 0.380 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 262 | 0.380 |
Why?
|
| Linkage Disequilibrium | 12 | 2024 | 1997 | 0.380 |
Why?
|
| Weight Gain | 6 | 2017 | 2359 | 0.370 |
Why?
|
| Proprotein Convertase 1 | 3 | 2015 | 10 | 0.370 |
Why?
|
| Heart Rate | 16 | 2015 | 4214 | 0.370 |
Why?
|
| Adipose Tissue | 18 | 2021 | 3329 | 0.370 |
Why?
|
| Hand Strength | 3 | 2019 | 466 | 0.370 |
Why?
|
| Income | 7 | 2023 | 1878 | 0.370 |
Why?
|
| Receptors, Nicotinic | 2 | 2015 | 494 | 0.360 |
Why?
|
| Deafness | 3 | 1999 | 460 | 0.360 |
Why?
|
| Publications | 1 | 2013 | 195 | 0.360 |
Why?
|
| Cyclin-Dependent Kinase 5 | 2 | 2010 | 110 | 0.360 |
Why?
|
| Primary Health Care | 12 | 2009 | 4746 | 0.360 |
Why?
|
| Receptor, Melanocortin, Type 4 | 3 | 2017 | 131 | 0.350 |
Why?
|
| Fatty Acids | 6 | 2023 | 1812 | 0.350 |
Why?
|
| Biomedical Research | 4 | 2024 | 3463 | 0.350 |
Why?
|
| Risk Assessment | 19 | 2020 | 24315 | 0.350 |
Why?
|
| Obesity, Abdominal | 2 | 2011 | 375 | 0.350 |
Why?
|
| Seasons | 2 | 2020 | 1524 | 0.340 |
Why?
|
| Metabolomics | 4 | 2024 | 1674 | 0.340 |
Why?
|
| Gastric Inhibitory Polypeptide | 2 | 2020 | 69 | 0.340 |
Why?
|
| Patient Selection | 4 | 2018 | 4260 | 0.340 |
Why?
|
| Lipid Metabolism | 7 | 2021 | 1904 | 0.340 |
Why?
|
| Anthropometry | 10 | 2019 | 1346 | 0.340 |
Why?
|
| Sleep | 3 | 2023 | 4819 | 0.340 |
Why?
|
| Abortifacient Agents, Nonsteroidal | 4 | 1999 | 65 | 0.340 |
Why?
|
| Glucagon-Like Peptide 1 | 3 | 2024 | 374 | 0.340 |
Why?
|
| Apolipoproteins E | 2 | 2016 | 1461 | 0.330 |
Why?
|
| Proportional Hazards Models | 30 | 2020 | 12543 | 0.320 |
Why?
|
| Epigenesis, Genetic | 8 | 2025 | 3833 | 0.320 |
Why?
|
| Feeding Behavior | 10 | 2023 | 3205 | 0.320 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2022 | 475 | 0.320 |
Why?
|
| Vaginal Smears | 3 | 2014 | 505 | 0.310 |
Why?
|
| Acceleration | 4 | 2013 | 189 | 0.300 |
Why?
|
| DNA Copy Number Variations | 2 | 2016 | 2048 | 0.300 |
Why?
|
| Monitoring, Physiologic | 3 | 2015 | 1798 | 0.300 |
Why?
|
| Body Fat Distribution | 6 | 2019 | 246 | 0.300 |
Why?
|
| Evidence-Based Medicine | 5 | 2023 | 3706 | 0.290 |
Why?
|
| Mental Health | 4 | 2020 | 3275 | 0.290 |
Why?
|
| Hydronephrosis | 1 | 2009 | 274 | 0.290 |
Why?
|
| Health Maintenance Organizations | 4 | 1999 | 657 | 0.290 |
Why?
|
| Fetal Blood | 3 | 2024 | 1361 | 0.290 |
Why?
|
| Anti-Obesity Agents | 1 | 2011 | 240 | 0.290 |
Why?
|
| United States | 51 | 2022 | 73039 | 0.290 |
Why?
|
| Cardiovascular Physiological Phenomena | 3 | 2019 | 241 | 0.290 |
Why?
|
| Chromans | 1 | 2007 | 116 | 0.290 |
Why?
|
| Sex Factors | 20 | 2021 | 10632 | 0.280 |
Why?
|
| Ascorbic Acid | 2 | 2020 | 658 | 0.280 |
Why?
|
| CpG Islands | 3 | 2025 | 1208 | 0.280 |
Why?
|
| Socioeconomic Factors | 17 | 2023 | 7852 | 0.280 |
Why?
|
| Eating | 5 | 2022 | 1542 | 0.280 |
Why?
|
| Gene Expression Regulation | 10 | 2020 | 11928 | 0.270 |
Why?
|
| Predictive Value of Tests | 11 | 2021 | 15454 | 0.270 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 404 | 0.270 |
Why?
|
| Genes | 2 | 2012 | 1824 | 0.270 |
Why?
|
| Health Surveys | 7 | 2017 | 4057 | 0.270 |
Why?
|
| Educational Status | 8 | 2012 | 2515 | 0.270 |
Why?
|
| Coffee | 2 | 2022 | 594 | 0.260 |
Why?
|
| Dietary Proteins | 4 | 2020 | 960 | 0.260 |
Why?
|
| Amino Acid Substitution | 2 | 2007 | 1743 | 0.260 |
Why?
|
| Adolescent | 54 | 2021 | 89169 | 0.260 |
Why?
|
| Misoprostol | 5 | 1999 | 94 | 0.260 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2016 | 542 | 0.260 |
Why?
|
| Guidelines as Topic | 2 | 2024 | 1397 | 0.260 |
Why?
|
| Meta-Analysis as Topic | 6 | 2017 | 1363 | 0.250 |
Why?
|
| Prescriptions | 1 | 2008 | 388 | 0.250 |
Why?
|
| Abortion, Induced | 5 | 1999 | 471 | 0.250 |
Why?
|
| Basal Metabolism | 2 | 2006 | 163 | 0.250 |
Why?
|
| Prevalence | 11 | 2023 | 15869 | 0.250 |
Why?
|
| Vitamin D | 4 | 2021 | 3311 | 0.240 |
Why?
|
| Follow-Up Studies | 34 | 2022 | 39348 | 0.240 |
Why?
|
| Fruit | 5 | 2020 | 1165 | 0.240 |
Why?
|
| Denmark | 10 | 2020 | 776 | 0.240 |
Why?
|
| Telomere | 3 | 2020 | 944 | 0.240 |
Why?
|
| Absorptiometry, Photon | 7 | 2016 | 1758 | 0.240 |
Why?
|
| Phospholipids | 3 | 2023 | 787 | 0.240 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2004 | 29 | 0.240 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 2043 | 0.240 |
Why?
|
| Iron | 3 | 2019 | 1813 | 0.240 |
Why?
|
| Specialization | 3 | 1998 | 779 | 0.240 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2006 | 360 | 0.240 |
Why?
|
| Young Adult | 28 | 2022 | 60066 | 0.240 |
Why?
|
| Tea | 2 | 2019 | 290 | 0.240 |
Why?
|
| C-Peptide | 3 | 2021 | 443 | 0.230 |
Why?
|
| Age of Onset | 7 | 2018 | 3347 | 0.230 |
Why?
|
| Referral and Consultation | 6 | 2000 | 3620 | 0.230 |
Why?
|
| Thiazolidinediones | 1 | 2007 | 461 | 0.230 |
Why?
|
| Leiomyoma | 1 | 2009 | 644 | 0.230 |
Why?
|
| Middle East | 2 | 2015 | 233 | 0.230 |
Why?
|
| Internationality | 2 | 2022 | 1008 | 0.230 |
Why?
|
| Environmental Exposure | 3 | 2016 | 4543 | 0.230 |
Why?
|
| Finland | 4 | 2020 | 609 | 0.230 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2018 | 1399 | 0.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2019 | 519 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7454 | 0.220 |
Why?
|
| Pre-Eclampsia | 3 | 2018 | 1255 | 0.220 |
Why?
|
| Risk | 16 | 2018 | 9613 | 0.220 |
Why?
|
| Muscle, Skeletal | 5 | 2013 | 4978 | 0.220 |
Why?
|
| Muscle, Smooth | 1 | 2007 | 931 | 0.210 |
Why?
|
| Bariatric Surgery | 2 | 2023 | 1001 | 0.210 |
Why?
|
| Physical Education and Training | 1 | 2003 | 102 | 0.210 |
Why?
|
| Adipocytes, Brown | 1 | 2024 | 160 | 0.210 |
Why?
|
| Genetic Markers | 3 | 2016 | 2603 | 0.210 |
Why?
|
| Sex Characteristics | 8 | 2022 | 2650 | 0.210 |
Why?
|
| Muscular Diseases | 1 | 2007 | 553 | 0.210 |
Why?
|
| Cation Transport Proteins | 4 | 2014 | 326 | 0.210 |
Why?
|
| New York | 9 | 2000 | 882 | 0.210 |
Why?
|
| Niacin | 1 | 2023 | 117 | 0.210 |
Why?
|
| Alcohol Drinking | 4 | 2019 | 4045 | 0.210 |
Why?
|
| Vegetables | 3 | 2020 | 1199 | 0.210 |
Why?
|
| Appetite | 2 | 2023 | 247 | 0.210 |
Why?
|
| Pregnant Women | 3 | 2023 | 576 | 0.210 |
Why?
|
| Diet, Mediterranean | 3 | 2023 | 748 | 0.210 |
Why?
|
| Meat | 3 | 2015 | 588 | 0.210 |
Why?
|
| Leg Ulcer | 2 | 2001 | 71 | 0.200 |
Why?
|
| Nutritional Status | 4 | 2022 | 1628 | 0.200 |
Why?
|
| Health Status Indicators | 5 | 2001 | 969 | 0.200 |
Why?
|
| Dairy Products | 2 | 2019 | 490 | 0.200 |
Why?
|
| Beverages | 4 | 2017 | 819 | 0.200 |
Why?
|
| Office Visits | 2 | 2004 | 595 | 0.200 |
Why?
|
| Inflammation | 8 | 2023 | 10873 | 0.200 |
Why?
|
| Quality of Life | 3 | 2020 | 13490 | 0.200 |
Why?
|
| Lipoproteins | 5 | 2023 | 880 | 0.200 |
Why?
|
| Health Services | 5 | 1999 | 755 | 0.200 |
Why?
|
| Patients | 2 | 1999 | 908 | 0.200 |
Why?
|
| Diet Surveys | 3 | 2021 | 1160 | 0.200 |
Why?
|
| Longitudinal Studies | 14 | 2022 | 14783 | 0.190 |
Why?
|
| Adipocytes | 3 | 2023 | 1197 | 0.190 |
Why?
|
| Nerve Tissue Proteins | 2 | 2019 | 4413 | 0.190 |
Why?
|
| Regression Analysis | 11 | 2015 | 6340 | 0.190 |
Why?
|
| Diet, Fat-Restricted | 2 | 2014 | 328 | 0.190 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2023 | 217 | 0.190 |
Why?
|
| Genetics, Population | 3 | 2017 | 944 | 0.190 |
Why?
|
| Medicine | 3 | 1998 | 945 | 0.190 |
Why?
|
| Protein Kinases | 1 | 2008 | 1611 | 0.180 |
Why?
|
| Self Report | 7 | 2022 | 3773 | 0.180 |
Why?
|
| Body Size | 2 | 2015 | 463 | 0.180 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2016 | 293 | 0.180 |
Why?
|
| Photoperiod | 1 | 2021 | 141 | 0.180 |
Why?
|
| Medical History Taking | 2 | 2017 | 779 | 0.180 |
Why?
|
| Abortifacient Agents, Steroidal | 2 | 1999 | 22 | 0.180 |
Why?
|
| Follistatin | 1 | 2021 | 138 | 0.180 |
Why?
|
| Hip | 2 | 2013 | 256 | 0.180 |
Why?
|
| Respiratory System | 1 | 2004 | 564 | 0.180 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 398 | 0.180 |
Why?
|
| Haplotypes | 8 | 2022 | 2722 | 0.180 |
Why?
|
| Wrist | 2 | 2013 | 231 | 0.180 |
Why?
|
| Fitness Centers | 1 | 2020 | 13 | 0.180 |
Why?
|
| Carrier Proteins | 1 | 2013 | 4937 | 0.180 |
Why?
|
| Pharmacogenetics | 2 | 2017 | 683 | 0.180 |
Why?
|
| Minority Groups | 4 | 2022 | 1216 | 0.170 |
Why?
|
| Uterine Neoplasms | 1 | 2009 | 1424 | 0.170 |
Why?
|
| Rural Health | 3 | 1991 | 302 | 0.170 |
Why?
|
| Islets of Langerhans | 3 | 2023 | 1351 | 0.170 |
Why?
|
| Population Surveillance | 3 | 2019 | 2596 | 0.170 |
Why?
|
| Sample Size | 3 | 2022 | 846 | 0.170 |
Why?
|
| Genetic Pleiotropy | 2 | 2022 | 181 | 0.170 |
Why?
|
| Health Plan Implementation | 2 | 2020 | 338 | 0.170 |
Why?
|
| Hyperlipidemias | 2 | 2023 | 772 | 0.170 |
Why?
|
| Gastrointestinal Transit | 1 | 2021 | 101 | 0.170 |
Why?
|
| Family Health | 2 | 2012 | 1255 | 0.170 |
Why?
|
| Insurance, Health | 7 | 2001 | 2517 | 0.170 |
Why?
|
| Genome, Human | 7 | 2022 | 4446 | 0.170 |
Why?
|
| Heredity | 2 | 2019 | 149 | 0.170 |
Why?
|
| Cardiovascular System | 2 | 2020 | 841 | 0.170 |
Why?
|
| Managed Care Programs | 3 | 2000 | 939 | 0.170 |
Why?
|
| Genetics | 1 | 2020 | 114 | 0.170 |
Why?
|
| Arteries | 1 | 2005 | 1127 | 0.170 |
Why?
|
| Inflammation Mediators | 3 | 2012 | 1892 | 0.170 |
Why?
|
| Mifepristone | 2 | 1999 | 151 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2005 | 846 | 0.170 |
Why?
|
| Equilibrative Nucleoside Transport Proteins | 1 | 2019 | 2 | 0.170 |
Why?
|
| Telephone | 2 | 2001 | 630 | 0.170 |
Why?
|
| Organic Cation Transporter 1 | 1 | 2019 | 8 | 0.170 |
Why?
|
| Nurse's Role | 1 | 2001 | 188 | 0.160 |
Why?
|
| Serum | 1 | 2020 | 206 | 0.160 |
Why?
|
| Family | 5 | 2014 | 3209 | 0.160 |
Why?
|
| Coronary Disease | 4 | 2016 | 5919 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2003 | 1247 | 0.160 |
Why?
|
| Proinsulin | 2 | 2011 | 135 | 0.160 |
Why?
|
| Glycemic Index | 1 | 2021 | 400 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 859 | 0.160 |
Why?
|
| Dietary Fiber | 3 | 2020 | 767 | 0.160 |
Why?
|
| Patient Satisfaction | 7 | 2001 | 3488 | 0.160 |
Why?
|
| Women's Health | 3 | 2017 | 2082 | 0.160 |
Why?
|
| Linear Models | 9 | 2016 | 5884 | 0.160 |
Why?
|
| Child | 32 | 2021 | 80917 | 0.160 |
Why?
|
| Computational Biology | 3 | 2020 | 3568 | 0.160 |
Why?
|
| Lactase | 1 | 2019 | 72 | 0.160 |
Why?
|
| Dentition, Permanent | 1 | 2018 | 22 | 0.160 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 558 | 0.160 |
Why?
|
| Reproducibility of Results | 17 | 2022 | 20227 | 0.160 |
Why?
|
| Financial Management | 1 | 2020 | 161 | 0.160 |
Why?
|
| Menopause | 3 | 2022 | 1656 | 0.160 |
Why?
|
| Stomatitis, Aphthous | 1 | 2019 | 51 | 0.160 |
Why?
|
| Patient Simulation | 1 | 2001 | 297 | 0.160 |
Why?
|
| Models, Biological | 10 | 2020 | 9495 | 0.150 |
Why?
|
| Parents | 2 | 2019 | 3595 | 0.150 |
Why?
|
| Models, Statistical | 5 | 2020 | 5107 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2017 | 127 | 0.150 |
Why?
|
| Logistic Models | 6 | 2015 | 13290 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2015 | 7608 | 0.150 |
Why?
|
| Tooth | 1 | 2020 | 210 | 0.150 |
Why?
|
| Oral Ulcer | 1 | 2019 | 96 | 0.150 |
Why?
|
| Medically Uninsured | 3 | 1993 | 840 | 0.150 |
Why?
|
| Multivariate Analysis | 11 | 2016 | 12077 | 0.150 |
Why?
|
| ROC Curve | 2 | 2020 | 3628 | 0.150 |
Why?
|
| Societies, Medical | 2 | 2020 | 3968 | 0.150 |
Why?
|
| Movement | 4 | 2013 | 1490 | 0.150 |
Why?
|
| Glucose-6-Phosphatase | 2 | 2015 | 71 | 0.150 |
Why?
|
| RNA-Binding Proteins | 4 | 2024 | 1890 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 507 | 0.150 |
Why?
|
| Fast Foods | 1 | 2020 | 220 | 0.150 |
Why?
|
| Arizona | 3 | 2007 | 108 | 0.150 |
Why?
|
| Meat Products | 2 | 2015 | 97 | 0.150 |
Why?
|
| Education | 1 | 2001 | 533 | 0.150 |
Why?
|
| Hemochromatosis | 1 | 2019 | 175 | 0.150 |
Why?
|
| Genetic Linkage | 2 | 2016 | 2342 | 0.150 |
Why?
|
| Medical Audit | 1 | 1999 | 454 | 0.140 |
Why?
|
| Time Factors | 13 | 2021 | 40218 | 0.140 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2017 | 605 | 0.140 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 3 | 2017 | 152 | 0.140 |
Why?
|
| Nucleotides | 1 | 2020 | 455 | 0.140 |
Why?
|
| Fibrinogen | 3 | 2015 | 891 | 0.140 |
Why?
|
| Health Care Surveys | 3 | 2001 | 2434 | 0.140 |
Why?
|
| Carotenoids | 1 | 2020 | 620 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8054 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 3 | 2023 | 1613 | 0.140 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2017 | 241 | 0.140 |
Why?
|
| Preventive Health Services | 3 | 2019 | 570 | 0.140 |
Why?
|
| Artifacts | 2 | 2005 | 1926 | 0.140 |
Why?
|
| Metagenome | 1 | 2021 | 465 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2001 | 599 | 0.140 |
Why?
|
| Morbidity | 1 | 2022 | 1755 | 0.140 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 979 | 0.140 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 2195 | 0.140 |
Why?
|
| Diet, Reducing | 3 | 2015 | 487 | 0.140 |
Why?
|
| Siblings | 2 | 2019 | 828 | 0.130 |
Why?
|
| Pedigree | 3 | 2018 | 4539 | 0.130 |
Why?
|
| Developing Countries | 3 | 2023 | 2910 | 0.130 |
Why?
|
| Confidence Intervals | 2 | 2020 | 2923 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 1197 | 0.130 |
Why?
|
| Age Factors | 13 | 2021 | 18412 | 0.130 |
Why?
|
| Tropomyosin | 1 | 2016 | 106 | 0.130 |
Why?
|
| Tooth Loss | 1 | 2018 | 200 | 0.130 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2011 | 706 | 0.130 |
Why?
|
| Trans-Activators | 2 | 2017 | 2857 | 0.130 |
Why?
|
| Health Services Research | 6 | 2000 | 1815 | 0.130 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2016 | 94 | 0.130 |
Why?
|
| Calorimetry | 3 | 2007 | 132 | 0.130 |
Why?
|
| Research Design | 3 | 2024 | 6211 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.130 |
Why?
|
| alpha-Linolenic Acid | 1 | 2016 | 144 | 0.130 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 3533 | 0.130 |
Why?
|
| Health Behavior | 5 | 2016 | 2650 | 0.130 |
Why?
|
| Disease | 1 | 2021 | 675 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Ventricular Dysfunction | 1 | 2016 | 144 | 0.130 |
Why?
|
| Angiopoietins | 1 | 2016 | 86 | 0.130 |
Why?
|
| Exercise Therapy | 3 | 2019 | 939 | 0.130 |
Why?
|
| Lipoprotein Lipase | 1 | 2016 | 133 | 0.130 |
Why?
|
| Methotrexate | 3 | 1997 | 1721 | 0.120 |
Why?
|
| Health Expenditures | 7 | 2000 | 2389 | 0.120 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2017 | 319 | 0.120 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2015 | 83 | 0.120 |
Why?
|
| Body Weights and Measures | 2 | 2013 | 208 | 0.120 |
Why?
|
| Reference Values | 3 | 2020 | 4938 | 0.120 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 1312 | 0.120 |
Why?
|
| Stroke | 5 | 2020 | 9755 | 0.120 |
Why?
|
| Monitoring, Ambulatory | 2 | 2011 | 358 | 0.120 |
Why?
|
| Physician-Patient Relations | 4 | 2001 | 3269 | 0.120 |
Why?
|
| Psychomotor Performance | 1 | 2003 | 1892 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 225 | 0.120 |
Why?
|
| Leisure Activities | 1 | 2016 | 310 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 22 | 0.120 |
Why?
|
| Postpartum Period | 2 | 2019 | 1198 | 0.120 |
Why?
|
| Demography | 2 | 2012 | 1641 | 0.120 |
Why?
|
| Diagnosis-Related Groups | 4 | 2000 | 445 | 0.120 |
Why?
|
| Wakefulness | 1 | 2021 | 1284 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2001 | 1078 | 0.120 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2018 | 10399 | 0.110 |
Why?
|
| Area Under Curve | 3 | 2010 | 1643 | 0.110 |
Why?
|
| Phosphofructokinase-1, Muscle Type | 1 | 2013 | 4 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2017 | 93 | 0.110 |
Why?
|
| Health Services Accessibility | 4 | 2019 | 5520 | 0.110 |
Why?
|
| Seafood | 2 | 2020 | 395 | 0.110 |
Why?
|
| Proline | 2 | 2007 | 455 | 0.110 |
Why?
|
| Fetal Development | 1 | 2019 | 779 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2021 | 2909 | 0.110 |
Why?
|
| Flavonols | 1 | 2013 | 84 | 0.110 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 736 | 0.110 |
Why?
|
| Flavonoids | 2 | 2013 | 447 | 0.110 |
Why?
|
| Colposcopy | 1 | 2014 | 151 | 0.110 |
Why?
|
| Metabolome | 1 | 2020 | 1009 | 0.110 |
Why?
|
| tRNA Methyltransferases | 2 | 2010 | 50 | 0.110 |
Why?
|
| Patient-Centered Care | 2 | 2020 | 1444 | 0.110 |
Why?
|
| Lysophospholipase | 2 | 2011 | 66 | 0.110 |
Why?
|
| Teaching | 1 | 2001 | 1171 | 0.110 |
Why?
|
| Exercise Test | 5 | 2013 | 2186 | 0.110 |
Why?
|
| Lignans | 1 | 2013 | 83 | 0.110 |
Why?
|
| Alanine | 2 | 2007 | 614 | 0.110 |
Why?
|
| Gynecology | 1 | 1999 | 534 | 0.110 |
Why?
|
| Databases, Factual | 5 | 2019 | 8080 | 0.100 |
Why?
|
| Oral Health | 1 | 2018 | 493 | 0.100 |
Why?
|
| Social Class | 2 | 2000 | 2008 | 0.100 |
Why?
|
| Receptors, Adiponectin | 1 | 2012 | 82 | 0.100 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 402 | 0.100 |
Why?
|
| Abdominal Fat | 2 | 2011 | 220 | 0.100 |
Why?
|
| Particle Size | 1 | 2016 | 1649 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2009 | 76 | 0.100 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2023 | 3228 | 0.100 |
Why?
|
| Hand | 1 | 2017 | 913 | 0.100 |
Why?
|
| Age Distribution | 2 | 2015 | 2873 | 0.100 |
Why?
|
| C-Reactive Protein | 3 | 2016 | 3858 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2016 | 751 | 0.100 |
Why?
|
| Drinking Behavior | 1 | 2012 | 103 | 0.100 |
Why?
|
| Epigenomics | 3 | 2025 | 960 | 0.100 |
Why?
|
| Aged, 80 and over | 14 | 2022 | 59629 | 0.100 |
Why?
|
| Disease Progression | 7 | 2022 | 13671 | 0.100 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2741 | 0.100 |
Why?
|
| Anorexia Nervosa | 1 | 2021 | 1364 | 0.090 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2011 | 72 | 0.090 |
Why?
|
| Trace Elements | 1 | 2013 | 193 | 0.090 |
Why?
|
| Feces | 3 | 2023 | 1511 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 856 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1143 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2013 | 301 | 0.090 |
Why?
|
| Nicotine | 1 | 1996 | 680 | 0.090 |
Why?
|
| Counseling | 2 | 2015 | 1554 | 0.090 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2001 | 243 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2012 | 801 | 0.090 |
Why?
|
| Heart | 1 | 2004 | 4446 | 0.090 |
Why?
|
| Neoplasms | 8 | 2023 | 22371 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3327 | 0.090 |
Why?
|
| Menarche | 1 | 2013 | 538 | 0.090 |
Why?
|
| Community Medicine | 1 | 1990 | 23 | 0.090 |
Why?
|
| Bed Rest | 1 | 2010 | 83 | 0.090 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2012 | 224 | 0.090 |
Why?
|
| Alcoholic Beverages | 1 | 2012 | 266 | 0.090 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2018 | 1567 | 0.090 |
Why?
|
| Cervix Uteri | 1 | 2014 | 577 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2019 | 1206 | 0.090 |
Why?
|
| Adipogenesis | 3 | 2021 | 370 | 0.090 |
Why?
|
| Health Care Costs | 5 | 2014 | 3239 | 0.090 |
Why?
|
| Public Health | 2 | 2020 | 2679 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 1551 | 0.090 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2013 | 395 | 0.090 |
Why?
|
| Nutrigenomics | 2 | 2022 | 23 | 0.090 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2010 | 40 | 0.090 |
Why?
|
| Metabolism | 1 | 2011 | 193 | 0.090 |
Why?
|
| Fetus | 1 | 2017 | 1883 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 923 | 0.090 |
Why?
|
| RNA, Messenger | 4 | 2023 | 12800 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 3711 | 0.080 |
Why?
|
| Likelihood Functions | 2 | 2007 | 994 | 0.080 |
Why?
|
| Weight-Bearing | 1 | 2012 | 534 | 0.080 |
Why?
|
| Potassium Channels | 3 | 2009 | 538 | 0.080 |
Why?
|
| Attitude of Health Personnel | 2 | 2001 | 3929 | 0.080 |
Why?
|
| Nutrition Surveys | 4 | 2018 | 1738 | 0.080 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 1752 | 0.080 |
Why?
|
| Child, Preschool | 10 | 2024 | 42669 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1596 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3800 | 0.080 |
Why?
|
| Docosahexaenoic Acids | 1 | 2016 | 914 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2020 | 3447 | 0.080 |
Why?
|
| Activities of Daily Living | 3 | 2013 | 2430 | 0.080 |
Why?
|
| Receptors, Drug | 2 | 2007 | 157 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2018 | 2451 | 0.080 |
Why?
|
| Software | 2 | 2021 | 4478 | 0.080 |
Why?
|
| Vaccination | 1 | 2022 | 3437 | 0.080 |
Why?
|
| Quality of Health Care | 5 | 2000 | 4310 | 0.080 |
Why?
|
| Magnesium | 1 | 2013 | 815 | 0.080 |
Why?
|
| Gestational Age | 3 | 2019 | 3621 | 0.080 |
Why?
|
| Transcription Factor AP-2 | 1 | 2009 | 78 | 0.080 |
Why?
|
| Cystoscopy | 1 | 2009 | 128 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2232 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2019 | 2538 | 0.080 |
Why?
|
| Estonia | 4 | 2011 | 56 | 0.080 |
Why?
|
| Hypercholesterolemia | 3 | 2010 | 1145 | 0.080 |
Why?
|
| Diet Records | 2 | 2016 | 426 | 0.080 |
Why?
|
| Blood Pressure Determination | 1 | 1993 | 646 | 0.080 |
Why?
|
| Clonidine | 1 | 1989 | 170 | 0.080 |
Why?
|
| Uric Acid | 1 | 2015 | 805 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2185 | 0.080 |
Why?
|
| Attitude to Health | 4 | 1999 | 2025 | 0.080 |
Why?
|
| Physical Exertion | 1 | 2001 | 668 | 0.080 |
Why?
|
| Receptors, Gastrointestinal Hormone | 2 | 2020 | 45 | 0.080 |
Why?
|
| Fishes | 1 | 2012 | 606 | 0.080 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 2 | 2007 | 144 | 0.080 |
Why?
|
| Membrane Transport Proteins | 3 | 2016 | 1037 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2009 | 710 | 0.080 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.080 |
Why?
|
| Circadian Rhythm | 2 | 2023 | 2593 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2001 | 4055 | 0.080 |
Why?
|
| Lipase | 1 | 2010 | 321 | 0.080 |
Why?
|
| Nutrition Assessment | 3 | 2019 | 740 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 1793 | 0.080 |
Why?
|
| Random Allocation | 3 | 2017 | 2396 | 0.080 |
Why?
|
| Carbonated Beverages | 3 | 2016 | 210 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2457 | 0.080 |
Why?
|
| Primary Prevention | 1 | 2015 | 1188 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2022 | 794 | 0.070 |
Why?
|
| Models, Genetic | 2 | 2016 | 3447 | 0.070 |
Why?
|
| Internal Medicine | 3 | 2001 | 1064 | 0.070 |
Why?
|
| Cause of Death | 3 | 2017 | 3721 | 0.070 |
Why?
|
| Causality | 3 | 2023 | 1254 | 0.070 |
Why?
|
| Economics, Medical | 2 | 1998 | 112 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2022 | 3433 | 0.070 |
Why?
|
| Infant | 7 | 2021 | 36535 | 0.070 |
Why?
|
| Algorithms | 3 | 2023 | 14164 | 0.070 |
Why?
|
| Animals | 15 | 2023 | 169246 | 0.070 |
Why?
|
| Placebos | 2 | 2012 | 1667 | 0.070 |
Why?
|
| Nurses | 1 | 2017 | 2501 | 0.070 |
Why?
|
| Poverty | 2 | 1997 | 2720 | 0.070 |
Why?
|
| Antiporters | 2 | 2019 | 276 | 0.070 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 1712 | 0.070 |
Why?
|
| Health Promotion | 1 | 2019 | 2210 | 0.070 |
Why?
|
| Zinc | 1 | 2011 | 677 | 0.070 |
Why?
|
| Pregnancy Complications | 3 | 2019 | 2973 | 0.070 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 1987 | 41 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2019 | 3841 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 2009 | 410 | 0.070 |
Why?
|
| Health Policy | 3 | 1997 | 2698 | 0.070 |
Why?
|
| Milk | 2 | 2020 | 438 | 0.070 |
Why?
|
| Pandemics | 3 | 2023 | 8748 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 138 | 0.070 |
Why?
|
| Clinical Competence | 2 | 2001 | 4858 | 0.070 |
Why?
|
| Satiety Response | 1 | 2006 | 47 | 0.070 |
Why?
|
| Echocardiography | 1 | 2019 | 5047 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2011 | 806 | 0.070 |
Why?
|
| Hospital Departments | 1 | 1987 | 135 | 0.070 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1990 | 538 | 0.070 |
Why?
|
| Chronic Disease | 5 | 2017 | 9384 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2298 | 0.070 |
Why?
|
| Diastole | 2 | 2019 | 785 | 0.070 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2007 | 567 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2021 | 2732 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 2 | 1999 | 3231 | 0.060 |
Why?
|
| Japan | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Liver | 2 | 2019 | 7577 | 0.060 |
Why?
|
| Germany | 2 | 2018 | 883 | 0.060 |
Why?
|
| Peptide YY | 1 | 2006 | 135 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2007 | 190 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2008 | 428 | 0.060 |
Why?
|
| Transferrin | 2 | 2017 | 283 | 0.060 |
Why?
|
| Deuterium | 1 | 2005 | 106 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2018 | 2819 | 0.060 |
Why?
|
| Cell Differentiation | 1 | 2023 | 11669 | 0.060 |
Why?
|
| Running | 3 | 2007 | 490 | 0.060 |
Why?
|
| Prognosis | 4 | 2021 | 30010 | 0.060 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 948 | 0.060 |
Why?
|
| Tuberculin Test | 1 | 1985 | 205 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2012 | 2937 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2016 | 144 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3573 | 0.060 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1990 | 956 | 0.060 |
Why?
|
| Pakistan | 2 | 2015 | 299 | 0.060 |
Why?
|
| Genetics, Medical | 1 | 2007 | 334 | 0.060 |
Why?
|
| Reproductive History | 2 | 2018 | 210 | 0.060 |
Why?
|
| Myocardial Infarction | 3 | 2018 | 11519 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2862 | 0.060 |
Why?
|
| Pregnancy in Diabetics | 1 | 2006 | 198 | 0.060 |
Why?
|
| Comorbidity | 2 | 2016 | 10590 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 1996 | 2085 | 0.060 |
Why?
|
| Obstetrics | 2 | 1991 | 681 | 0.060 |
Why?
|
| Ferritins | 2 | 2017 | 601 | 0.060 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9538 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 1606 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 472 | 0.060 |
Why?
|
| Hunger | 2 | 2021 | 207 | 0.060 |
Why?
|
| Jet Lag Syndrome | 1 | 2023 | 24 | 0.050 |
Why?
|
| Spain | 1 | 2005 | 485 | 0.050 |
Why?
|
| Ketone Bodies | 1 | 2023 | 76 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2017 | 263 | 0.050 |
Why?
|
| Mass Screening | 3 | 1993 | 5458 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5367 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2006 | 587 | 0.050 |
Why?
|
| Locomotion | 1 | 2005 | 388 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2023 | 65371 | 0.050 |
Why?
|
| Mental Disorders | 1 | 2023 | 6874 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 1997 | 4530 | 0.050 |
Why?
|
| Phylogeny | 1 | 2010 | 2843 | 0.050 |
Why?
|
| Physiology | 1 | 2003 | 112 | 0.050 |
Why?
|
| Repressor Proteins | 2 | 2017 | 2982 | 0.050 |
Why?
|
| Elasticity | 1 | 2005 | 656 | 0.050 |
Why?
|
| Erythrocytes | 1 | 2012 | 2418 | 0.050 |
Why?
|
| Walking | 3 | 2007 | 1201 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4120 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2023 | 239 | 0.050 |
Why?
|
| Glycine | 1 | 2006 | 672 | 0.050 |
Why?
|
| Physical Endurance | 1 | 2005 | 369 | 0.050 |
Why?
|
| Alanine Transaminase | 2 | 2016 | 606 | 0.050 |
Why?
|
| Abdomen | 1 | 2008 | 1136 | 0.050 |
Why?
|
| Communicable Diseases | 1 | 2010 | 874 | 0.050 |
Why?
|
| Fatty Acids, Volatile | 1 | 2023 | 100 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Lysine | 1 | 2007 | 1000 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2000 | 10101 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2012 | 2589 | 0.050 |
Why?
|
| Mammography | 1 | 1993 | 2433 | 0.050 |
Why?
|
| Serine | 1 | 2006 | 831 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 3 | 1998 | 1741 | 0.050 |
Why?
|
| Africa | 1 | 2024 | 725 | 0.050 |
Why?
|
| Policy Making | 2 | 1997 | 546 | 0.050 |
Why?
|
| Glycoproteins | 2 | 2021 | 2202 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3251 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2024 | 898 | 0.050 |
Why?
|
| England | 2 | 2020 | 533 | 0.050 |
Why?
|
| GATA5 Transcription Factor | 1 | 2020 | 18 | 0.050 |
Why?
|
| Drug Therapy, Combination | 5 | 2016 | 6316 | 0.050 |
Why?
|
| Bread | 1 | 2020 | 23 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 183 | 0.050 |
Why?
|
| Phospholipase C beta | 1 | 2020 | 49 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 13421 | 0.050 |
Why?
|
| Pilot Projects | 3 | 2018 | 8741 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2021 | 84 | 0.050 |
Why?
|
| Satiation | 1 | 2021 | 84 | 0.050 |
Why?
|
| Prevotella | 1 | 2021 | 81 | 0.050 |
Why?
|
| Food Microbiology | 1 | 2021 | 74 | 0.050 |
Why?
|
| Pancreatic Function Tests | 1 | 2021 | 69 | 0.050 |
Why?
|
| Oxygenases | 1 | 2020 | 59 | 0.050 |
Why?
|
| Video Games | 1 | 2003 | 202 | 0.040 |
Why?
|
| Blastocystis | 1 | 2021 | 21 | 0.040 |
Why?
|
| Drosophila | 2 | 2019 | 1513 | 0.040 |
Why?
|
| Population Groups | 1 | 2021 | 209 | 0.040 |
Why?
|
| Vagus Nerve | 1 | 2003 | 459 | 0.040 |
Why?
|
| Bacteroides | 1 | 2021 | 165 | 0.040 |
Why?
|
| Mutation, Missense | 3 | 2017 | 2592 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2021 | 380 | 0.040 |
Why?
|
| Administration, Intravaginal | 2 | 1999 | 149 | 0.040 |
Why?
|
| Yogurt | 1 | 2020 | 71 | 0.040 |
Why?
|
| Mice | 7 | 2023 | 82029 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2012 | 2062 | 0.040 |
Why?
|
| Physicians | 1 | 1998 | 4598 | 0.040 |
Why?
|
| Ontario | 1 | 2001 | 403 | 0.040 |
Why?
|
| Sentinel Surveillance | 1 | 2022 | 292 | 0.040 |
Why?
|
| Empirical Research | 1 | 2000 | 119 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2019 | 25 | 0.040 |
Why?
|
| Censuses | 1 | 2001 | 198 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2017 | 1656 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 216 | 0.040 |
Why?
|
| RNA Interference | 1 | 2008 | 2832 | 0.040 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2011 | 170 | 0.040 |
Why?
|
| Self Administration | 2 | 1999 | 386 | 0.040 |
Why?
|
| Australia | 1 | 2023 | 1265 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 6526 | 0.040 |
Why?
|
| Receptors, Vasopressin | 1 | 2019 | 106 | 0.040 |
Why?
|
| Molar | 1 | 2020 | 155 | 0.040 |
Why?
|
| Caspase 9 | 1 | 2019 | 184 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2022 | 373 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2021 | 81762 | 0.040 |
Why?
|
| Expert Testimony | 1 | 2020 | 266 | 0.040 |
Why?
|
| Rural Population | 1 | 1990 | 2325 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15948 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1715 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1985 | 843 | 0.040 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5315 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 832 | 0.040 |
Why?
|
| Infant, Newborn | 8 | 2021 | 26422 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 1056 | 0.040 |
Why?
|
| DMF Index | 1 | 2018 | 87 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2000 | 615 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 3780 | 0.040 |
Why?
|
| Research Personnel | 1 | 2023 | 589 | 0.040 |
Why?
|
| Gene Expression | 3 | 2021 | 7598 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 1983 | 696 | 0.040 |
Why?
|
| Individuality | 1 | 2020 | 307 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2021 | 565 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 491 | 0.040 |
Why?
|
| Periodontal Index | 1 | 2018 | 152 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2010 | 6004 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 2019 | 612 | 0.040 |
Why?
|
| Mutation | 3 | 2020 | 30238 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2003 | 1525 | 0.040 |
Why?
|
| Reminder Systems | 1 | 2001 | 388 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2023 | 1191 | 0.040 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 286 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 3 | 1997 | 917 | 0.040 |
Why?
|
| Caveolin 2 | 1 | 2017 | 25 | 0.040 |
Why?
|
| Dipeptidases | 1 | 2017 | 38 | 0.040 |
Why?
|
| Laboratories, Hospital | 1 | 1999 | 192 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 13676 | 0.040 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 141 | 0.040 |
Why?
|
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 14 | 0.040 |
Why?
|
| Therapeutic Irrigation | 1 | 1998 | 297 | 0.040 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2017 | 19 | 0.040 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2017 | 134 | 0.040 |
Why?
|
| Glucokinase | 1 | 2017 | 99 | 0.040 |
Why?
|
| Metagenomics | 1 | 2021 | 474 | 0.040 |
Why?
|
| Appointments and Schedules | 1 | 2001 | 443 | 0.030 |
Why?
|
| Health | 1 | 1980 | 398 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2017 | 1758 | 0.030 |
Why?
|
| Reference Standards | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Norway | 2 | 2011 | 501 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3445 | 0.030 |
Why?
|
| Respiration | 1 | 2003 | 1665 | 0.030 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 60 | 0.030 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2016 | 64 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2001 | 1003 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 41 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2023 | 1024 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 1999 | 365 | 0.030 |
Why?
|
| Iceland | 1 | 2016 | 183 | 0.030 |
Why?
|
| Somatomedins | 1 | 2017 | 179 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2017 | 174 | 0.030 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2016 | 48 | 0.030 |
Why?
|
| Aging | 2 | 2006 | 8744 | 0.030 |
Why?
|
| Sodium-Glucose Transporter 1 | 1 | 2016 | 108 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2016 | 93 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2018 | 591 | 0.030 |
Why?
|
| Access to Information | 1 | 2019 | 317 | 0.030 |
Why?
|
| Mouth Diseases | 1 | 2018 | 239 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 473 | 0.030 |
Why?
|
| Rest | 2 | 2015 | 948 | 0.030 |
Why?
|
| Poverty Areas | 1 | 1997 | 268 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 14729 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 812 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 937 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2001 | 829 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 845 | 0.030 |
Why?
|
| Uterine Hemorrhage | 1 | 1997 | 236 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12421 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2005 | 6412 | 0.030 |
Why?
|
| Interferon Regulatory Factors | 1 | 2017 | 271 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2000 | 744 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 3 | 1998 | 5536 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 138 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2019 | 592 | 0.030 |
Why?
|
| Margarine | 1 | 2014 | 17 | 0.030 |
Why?
|
| Professional Practice | 1 | 1997 | 314 | 0.030 |
Why?
|
| Butter | 1 | 2014 | 22 | 0.030 |
Why?
|
| Serum Amyloid A Protein | 1 | 2015 | 128 | 0.030 |
Why?
|
| Fats | 1 | 2015 | 99 | 0.030 |
Why?
|
| Culture | 1 | 1999 | 622 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 8759 | 0.030 |
Why?
|
| Cognition | 1 | 2012 | 7073 | 0.030 |
Why?
|
| Netherlands | 1 | 2020 | 2277 | 0.030 |
Why?
|
| Multigene Family | 1 | 2018 | 1081 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2001 | 939 | 0.030 |
Why?
|
| Medical Staff, Hospital | 1 | 1999 | 603 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 68 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3671 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2016 | 290 | 0.030 |
Why?
|
| Cell Line | 2 | 2023 | 15597 | 0.030 |
Why?
|
| Brazil | 1 | 2019 | 1250 | 0.030 |
Why?
|
| Periodontal Diseases | 1 | 2018 | 455 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2023 | 2872 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2021 | 1247 | 0.030 |
Why?
|
| Autoantibodies | 1 | 2023 | 2121 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 36743 | 0.030 |
Why?
|
| HIV Infections | 1 | 2001 | 17569 | 0.030 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 252 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2021 | 23645 | 0.030 |
Why?
|
| Proanthocyanidins | 1 | 2013 | 20 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2016 | 2173 | 0.030 |
Why?
|
| Deuterium Oxide | 1 | 2013 | 34 | 0.030 |
Why?
|
| Risk-Taking | 1 | 2000 | 1023 | 0.030 |
Why?
|
| Simvastatin | 1 | 2016 | 346 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2017 | 2429 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 1083 | 0.030 |
Why?
|
| Oxygen Isotopes | 1 | 2013 | 43 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 362 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 611 | 0.030 |
Why?
|
| Receptors, LDL | 1 | 2016 | 493 | 0.030 |
Why?
|
| DNA | 1 | 2007 | 7214 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 1996 | 716 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2014 | 263 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1998 | 871 | 0.030 |
Why?
|
| Plant Oils | 1 | 2014 | 199 | 0.030 |
Why?
|
| Scotland | 1 | 2013 | 142 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2003 | 2819 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 1049 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 809 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 1074 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 753 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 1165 | 0.030 |
Why?
|
| Fabaceae | 1 | 2013 | 103 | 0.030 |
Why?
|
| Gravitation | 1 | 2013 | 82 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 527 | 0.030 |
Why?
|
| Heart Conduction System | 1 | 2018 | 1009 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 1997 | 643 | 0.030 |
Why?
|
| Aminopeptidases | 1 | 2013 | 114 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 2227 | 0.030 |
Why?
|
| Vagina | 1 | 1998 | 850 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 858 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1999 | 2357 | 0.030 |
Why?
|
| Calibration | 2 | 2007 | 819 | 0.030 |
Why?
|
| Research Report | 1 | 2016 | 369 | 0.030 |
Why?
|
| Nuts | 1 | 2014 | 264 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2001 | 2507 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1983 | 2784 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1133 | 0.020 |
Why?
|
| Television | 1 | 2015 | 410 | 0.020 |
Why?
|
| Urban Population | 1 | 2000 | 2046 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2017 | 771 | 0.020 |
Why?
|
| Plant Roots | 1 | 2012 | 122 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 141 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 325 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2012 | 153 | 0.020 |
Why?
|
| Methylene Chloride | 1 | 1991 | 11 | 0.020 |
Why?
|
| Iron, Dietary | 1 | 2012 | 148 | 0.020 |
Why?
|
| Glycerol | 1 | 2012 | 274 | 0.020 |
Why?
|
| Validation Studies as Topic | 1 | 2012 | 162 | 0.020 |
Why?
|
| Lipolysis | 1 | 2012 | 211 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 1470 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2012 | 657 | 0.020 |
Why?
|
| Syndrome | 1 | 2017 | 3272 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 8542 | 0.020 |
Why?
|
| Recreation | 1 | 2011 | 124 | 0.020 |
Why?
|
| Mitochondria, Muscle | 1 | 2012 | 172 | 0.020 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 1117 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2019 | 1475 | 0.020 |
Why?
|
| Beer | 1 | 2011 | 135 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3814 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2013 | 290 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2014 | 677 | 0.020 |
Why?
|
| Hemeproteins | 1 | 2010 | 61 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 1992 | 246 | 0.020 |
Why?
|
| Chromatin | 1 | 2022 | 2981 | 0.020 |
Why?
|
| Proteome | 1 | 2020 | 1890 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2017 | 1089 | 0.020 |
Why?
|
| Wine | 1 | 2011 | 172 | 0.020 |
Why?
|
| Longevity | 1 | 1998 | 1077 | 0.020 |
Why?
|
| Malnutrition | 1 | 2017 | 632 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2021 | 4176 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3436 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 472 | 0.020 |
Why?
|
| Popliteal Vein | 1 | 1990 | 43 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2017 | 1015 | 0.020 |
Why?
|
| Patient Advocacy | 1 | 1992 | 362 | 0.020 |
Why?
|
| Cost Control | 1 | 1992 | 627 | 0.020 |
Why?
|
| Patient Education as Topic | 2 | 2011 | 2337 | 0.020 |
Why?
|
| Actins | 1 | 2017 | 2064 | 0.020 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 493 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2016 | 12465 | 0.020 |
Why?
|
| Femoral Vein | 1 | 1990 | 155 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 1990 | 424 | 0.020 |
Why?
|
| Epinephrine | 1 | 2012 | 794 | 0.020 |
Why?
|
| France | 1 | 2010 | 497 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2810 | 0.020 |
Why?
|
| Registries | 2 | 2018 | 8375 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2015 | 1191 | 0.020 |
Why?
|
| Water | 1 | 2015 | 1421 | 0.020 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2009 | 77 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2085 | 0.020 |
Why?
|
| Patient Compliance | 2 | 2009 | 2697 | 0.020 |
Why?
|
| Community Health Centers | 1 | 1993 | 469 | 0.020 |
Why?
|
| Polytetrafluoroethylene | 1 | 1990 | 245 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2019 | 4194 | 0.020 |
Why?
|
| Colon | 1 | 2017 | 1801 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 213 | 0.020 |
Why?
|
| Prejudice | 1 | 1993 | 574 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3886 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2000 | 1946 | 0.020 |
Why?
|
| Mental Recall | 1 | 2014 | 1226 | 0.020 |
Why?
|
| Labor, Obstetric | 1 | 1991 | 323 | 0.020 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2010 | 263 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2015 | 1369 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2020 | 3445 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2016 | 1726 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 9615 | 0.020 |
Why?
|
| Depression | 2 | 1997 | 8230 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2008 | 311 | 0.020 |
Why?
|
| Physical Examination | 2 | 2004 | 1263 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 873 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 1989 | 0.020 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2008 | 167 | 0.020 |
Why?
|
| Binding Sites | 1 | 2015 | 6020 | 0.020 |
Why?
|
| Physicians, Women | 1 | 1993 | 517 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1751 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 20760 | 0.020 |
Why?
|
| Kidney | 1 | 2022 | 7064 | 0.020 |
Why?
|
| Robotics | 1 | 2013 | 812 | 0.020 |
Why?
|
| Medicaid | 2 | 1997 | 2840 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 1997 | 2783 | 0.020 |
Why?
|
| Behavior | 1 | 2009 | 542 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2010 | 2000 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 1996 | 2008 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6229 | 0.020 |
Why?
|
| Body Constitution | 1 | 2006 | 273 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2020 | 2442 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2016 | 2145 | 0.020 |
Why?
|
| Physician's Role | 1 | 1992 | 925 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 21206 | 0.020 |
Why?
|
| Synapses | 1 | 2015 | 1765 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6283 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1987 | 151 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2019 | 5622 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3603 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 1990 | 1328 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4786 | 0.010 |
Why?
|
| Sternum | 1 | 2005 | 177 | 0.010 |
Why?
|
| International Cooperation | 1 | 2011 | 1436 | 0.010 |
Why?
|
| Portugal | 1 | 2004 | 91 | 0.010 |
Why?
|
| Peptides | 1 | 2016 | 4354 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 2004 | 164 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1737 | 0.010 |
Why?
|
| Hip Fractures | 1 | 2012 | 997 | 0.010 |
Why?
|
| Delivery, Obstetric | 1 | 1991 | 954 | 0.010 |
Why?
|
| Medical Records | 1 | 1989 | 1410 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 2005 | 255 | 0.010 |
Why?
|
| Ribs | 1 | 2005 | 259 | 0.010 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2003 | 61 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1989 | 966 | 0.010 |
Why?
|
| SOS1 Protein | 1 | 2003 | 40 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2394 | 0.010 |
Why?
|
| Calorimetry, Indirect | 1 | 2004 | 176 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 325 | 0.010 |
Why?
|
| Health Education | 1 | 1990 | 1059 | 0.010 |
Why?
|
| Electrodes | 1 | 2005 | 617 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 515 | 0.010 |
Why?
|
| Homozygote | 1 | 2008 | 1779 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1996 | 4206 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 1151 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2015 | 5151 | 0.010 |
Why?
|
| Recurrence | 1 | 2015 | 8509 | 0.010 |
Why?
|
| Costs and Cost Analysis | 2 | 1992 | 1667 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5804 | 0.010 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 1469 | 0.010 |
Why?
|
| Infant Mortality | 1 | 1987 | 752 | 0.010 |
Why?
|
| Mothers | 1 | 2012 | 2209 | 0.010 |
Why?
|
| Anxiety | 1 | 1997 | 4672 | 0.010 |
Why?
|
| Asthma | 1 | 2020 | 6291 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 10266 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 3428 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19015 | 0.010 |
Why?
|
| Ion Channels | 1 | 2005 | 1043 | 0.010 |
Why?
|
| Insurance, Major Medical | 1 | 2000 | 12 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1983 | 1627 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2017 | 4887 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 839 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22379 | 0.010 |
Why?
|
| Financing, Government | 1 | 1983 | 473 | 0.010 |
Why?
|
| Medicare | 1 | 1997 | 6809 | 0.010 |
Why?
|
| Internship and Residency | 1 | 1999 | 5953 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 4168 | 0.010 |
Why?
|
| Gait | 1 | 2003 | 823 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 1996 | 4860 | 0.010 |
Why?
|
| Quality Control | 1 | 2000 | 836 | 0.010 |
Why?
|
| Family Planning Services | 1 | 1980 | 279 | 0.010 |
Why?
|
| Air Pollutants | 1 | 1991 | 2916 | 0.010 |
Why?
|
| Uterus | 1 | 1999 | 663 | 0.010 |
Why?
|
| History, 20th Century | 1 | 1983 | 2766 | 0.010 |
Why?
|
| Abortion, Legal | 1 | 1996 | 121 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 1983 | 1226 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2885 | 0.010 |
Why?
|
| Chorionic Gonadotropin | 1 | 1995 | 458 | 0.010 |
Why?
|
| Episiotomy | 1 | 1991 | 21 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 1991 | 70 | 0.010 |
Why?
|
| State Medicine | 1 | 1993 | 219 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1999 | 4030 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1999 | 1673 | 0.010 |
Why?
|
| Labor, Induced | 1 | 1991 | 156 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 1998 | 1406 | 0.010 |
Why?
|
| Maternal Age | 1 | 1991 | 805 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1999 | 2972 | 0.000 |
Why?
|
| Federal Government | 1 | 1989 | 266 | 0.000 |
Why?
|
| Posture | 1 | 1991 | 957 | 0.000 |
Why?
|
| Antihypertensive Agents | 1 | 1997 | 2029 | 0.000 |
Why?
|
| Resource Allocation | 1 | 1989 | 354 | 0.000 |
Why?
|
| Cost of Illness | 1 | 1993 | 1951 | 0.000 |
Why?
|
| Hospitalization | 1 | 1996 | 10840 | 0.000 |
Why?
|